LeeSY,LeeKJ,KimSJ,Cho SW, 2009.Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study,Digestion 79 196 -201
Locke 3rdGR,TalleyNJ,FettSL,ZinsmeisterAR, 1997.Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota, 112 1448 -56
PetersenH., 1995.The prevalence of gastrooesophageal reflux disease,Scand J Gastroenterol 30 5 -6
DentJ,El-SeragHB,WallanderM,JohanssonS., 2005.Epidemiology of gastro-oesophageal reflux disease: a systematic review,Gut 54 710 -7
McDougallNI,JohnstonBT,KeeF,CollinsJS,McFarlandRJ,LoveAH, .Natural history of reflux oesophagitis: a 10 year follow up of its effect on, -
FarupC,KleinmanL,SloanS,GanoczyD,CheeE,LeeC,RevickiD., 2001.The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life,Arch Intern Med 161 45 -52
YangYX,LewisJD,EpsteinS,MetzDC, .Longterm proton pump inhibitor therapy and risk of hip fracture,JAMA. 2006 Dec 296 2947 -53
AmentPW,DicolaDB,JamesME, 2012.Reducing adverse effects of proton pump inhibitors,Am Fam Physician 86 66 -70
RonkainenJ,AroP,StorskrubbT,LindT,Bolling‐SternevaldE,JunghardO,TalleyNJ, 2006.Gastro‐oesophageal reflux symptoms and health‐related quality of life in the adult general population-the Kalixanda study,Aliment Pharmacol Ther 23 1725 -33
WahlqvistP,ReillyMC,BarkunA, 2006.Systematic review: the impact of gastro‐oesophageal reflux disease on work productivity,Aliment Pharmacol Ther 24 259 -72
LagergrenJ,BergströmR,LindgrenA,NyrénO, 1999.Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma,N Engl J Med 340 825 -31
EdgrenG,AdamiHO,WeiderpassE,NyrénO., 2013.A global assessment of the oesophageal adenocarcinoma epidemic,Gut 62 1406 -14
MasonJ,HunginAP, 2005.gastro‐oesophageal reflux disease-the health economic implications,Aliment Pharmacol Ther 22 20 -31
MittalRK,BalabanDH, 1997.The esophagogastric junction,N Engl J Med 336 924 -32
HershcoviciT,MashimoH,FassR., 2011.The lower esophageal sphincter,Neurogastroenterol Motil 23 819 -30
KessingBF,ConchilloJM,BredenoordAJ,SmoutAJ,MascleeAA., 2011.the clinical relevance of transient lower oesophageal sphincter relaxations in gastro‐oesophageal reflux disease,Aliment Pharmacol Ther 33 650 -61
PenaginiR,BraviI., 2010.The role of delayed gastric emptying and impaired oesophageal body motility,Best Pract Res Clin Gastroenterol 24 831 -45
KandulskiA,MalfertheinerP, 2012.Gastroesophageal reflux disease-from reflux episodes to mucosal inflammation,Nat Rev Gastroenterol Hepatol 9 15 -
PandolfinoJE,El-SeragHB,ZhangQ,ShahN,GhoshSK,KahrilasPJ, 2006.Obesity: a challenge to esophagogastric junction integrity,Gastroenterology 130 639 -49
KahrilasPJ,GuptaRR, 1989.The effect of cigarette smoking on salivation and esophageal acid clearance,J Lab Clin Med 114 431 -8
DennishGW,CastellDO, 1971.The Inhibitory Effect of Smoking on the Lower Esophageal Sphincter,Ann Intern Med 74 834 -
DentJ,El-SeragHB,WallanderM,JohanssonS., 2005.Epidemiology of gastro-oesophageal reflux disease: a systematic review,Gut 54 710 -7
HampelH,AbrahamNS,El-SeragHB, 2005.Metaanalysis: obesity and the risk for gastroesophageal reflux disease and its complications,Ann Intern Med 143 199 -211
NilssonM,JohnsenR,YeW,HveemK,LagergrenJ, 2003.Obesity and estrogen as risk factors for gastroesophageal reflux symptoms,JAMA 290 66 -72
NilssonM,JohnsenR,YeW,HveemK,LagergrenJ, 2004.Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux,Gut 53 1730 -5
CookMB,WildCP,FormanD., 2005.A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease,Am J Epidemiol 162 1050 -61
BecherA,DentJ, 2011.Systematic review: ageing and gastro‐oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis,Aliment Pharmacol Ther 33 442 -54
FlegalKM,CarrollMD,OgdenCL,JohnsonCL, 2002.Prevalence and trends in obesity among US adults,, 288 1723 -7
SinghS,SharmaAN,MuradMH,ButtarNS,ElSeragHB,KatzkaDA,IyerPG, .Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a, -
VakilN,Van ZantenSV,KahrilasP,DentJ,JonesR., 2006.The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus,Am J Gastroenterol 101 1900 -20
ArmstrongD,MarshallJK,ChibaN,EnnsR,FalloneCA,FassR,HollingworthR,HuntRH,KahrilasPJ,MayrandS,MoayyediP.,Canadian Consensus,Can J Gastroenterol Hepatol, 2005.Conference on the management of gastroesophageal reflux disease in adults-update 2004, 19 15 -35
TeferaL,FeinM,RitterMP,BremnerCG,CrookesPF,PetersJH,HagenJA, 1997.Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?,Am Surg 63 933 -6
KahrilasPJ,QuigleyEM., 1996.Clinical esophageal pH recording: a technical review for practice guideline development,Gastroenterology 110 1982 -96
HiranoI,RichterJE, 2007.ACG practice guidelines: esophageal reflux testing,Am J Gastroenterol 102 668 -
ReimerC,SøndergaardB,HilstedL,BytzerP, 2009.Proton-pump inhibitor therapy induces acidrelated symptoms in healthy volunteers after withdrawal of therapy,Gastroenterology 137 80 -7
BavishiC,DupontHL, 2011.Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection,Aliment Pharmacol Ther 34 1269 -81
JohnstoneJ,NerenbergK,LoebM, 2010.Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia,Aliment Pharmacol Ther 31 1165 -77
NgamruengphongS,LeontiadisGI,RadhiS,DentinoA,NugentK., 2011.Proton pump inhibitors and risk of fracture: a systematic review and metaanalysis of observational studies,Am J Gastroenterol 106 1209 -